ARCUTIS BIOTHERAPEUTICS INC (ARQT) Institutional Shareholders

ARCUTIS BIOTHERAPEUTICS INC (ARQT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $3.38B in ARQT holdings during the latest filing period.

Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of ARQT tracked by InsiderSet, reporting ownership valued at approximately $326.10M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $325.73M, representing an estimated loss of -0.11% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 55% of the total disclosed ARQT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Blackrock, Inc., Frazier Life Sciences Management, L.P., and several other long-term asset managers with concentrated positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT).

This page ranks the largest institutional ARQT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

268

Total Reported Value

$3.38B

Largest Holder

Suvretta Capital Management, Llc

Largest Position

$326.10M

Insider Transactions (90d)

24

Latest Filing Quarter

Q2 2026

New Institutional Positions

48

Funds Exiting Positions

0

Page 1 of 6
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Suvretta Capital Management, Llc6.85%12,437,000$326,098,140$325,725,030-$373,110-0.11%
Blackrock, Inc.0.00%10,545,466$276,502,120$276,185,755-$316,365-0.11%
Frazier Life Sciences Management, L.P.5.64%9,874,511$258,909,678$258,613,443-$296,235-0.11%
Rubric Capital Management Lp1.99%8,271,577$216,880,749$216,632,602-$248,147-0.11%
Polar Capital Holdings Plc0.49%6,606,945$173,234,098$173,035,890-$198,208-0.11%
State Street Corp0.00%5,822,840$152,674,865$152,500,180-$174,685-0.11%
Vanguard Capital Management Llc0.00%4,988,756$130,805,182$130,655,520-$149,662-0.11%
Morgan Stanley0.01%4,451,014$116,705,607$116,572,057-$133,550-0.11%
Jennison Associates Llc0.07%4,219,058$110,623,703$110,497,129-$126,574-0.11%
D. E. Shaw & Co., Inc.0.06%3,949,609$103,558,748$103,440,260-$118,488-0.11%
Ubs Group Ag0.01%3,333,015$87,391,654$87,291,663-$99,991-0.11%
Bank Of America Corp0.01%2,987,431$78,330,441$78,240,818-$89,623-0.11%
Geode Capital Management, Llc0.00%2,982,446$78,214,092$78,110,261-$103,831-0.13%
Vanguard Portfolio Management Llc0.00%2,429,005$63,688,511$63,615,641-$72,870-0.11%
Orbimed Advisors Llc1.01%2,042,000$53,541,240$53,479,980-$61,260-0.11%
American Century Companies Inc0.02%1,925,031$50,474,363$50,416,562-$57,801-0.11%
Goldman Sachs Group Inc0.00%1,668,367$43,744,582$43,694,532-$50,050-0.11%
Janus Henderson Group Plc0.02%1,854,566$43,684,303$48,571,084+$4,886,781+11.19%
Oberweis Asset Management Inc/0.74%1,372,941$35,998,513$35,957,325-$41,188-0.11%
Gilder Gagnon Howe & Co Llc0.36%1,313,211$34,432,392$34,392,996-$39,396-0.11%
Pivotal Bioventure Partners Investment Advisor Llc10.78%1,265,283$33,175,720$33,137,762-$37,958-0.11%
Bamco Inc0.05%1,253,120$32,856,806$32,819,213-$37,593-0.11%
Citadel Advisors Llc0.02%1,160,014$30,415,567$30,380,767-$34,800-0.11%
Federated Hermes, Inc.0.04%1,124,629$29,487,772$29,454,034-$33,738-0.11%
Perpetual Ltd0.42%1,109,657$29,095,206$29,061,917-$33,289-0.11%
Aberdeen Group Plc0.04%1,098,411$28,800,336$28,767,384-$32,952-0.11%
Jones Hill Capital Lp6.07%1,089,701$28,571,960$28,539,269-$32,691-0.11%
Northern Trust Corp0.00%1,058,575$27,755,837$27,724,079-$31,758-0.11%
Charles Schwab Investment Management Inc0.00%1,050,934$27,555,489$27,523,961-$31,528-0.11%
Sixth Street Partners Management Company, L.P.0.00%1,050,934$27,555,489$27,523,961-$31,528-0.11%
Ensign Peak Advisors, Inc0.04%974,534$25,552,281$25,523,045-$29,236-0.11%
Candriam S.C.A.0.11%949,839$24,880,817$24,876,283-$4,534-0.02%
Driehaus Capital Management Llc0.13%878,426$23,032,330$23,005,977-$26,353-0.11%
Nuveen, Llc0.01%834,261$21,874,324$21,849,296-$25,028-0.11%
Vanguard Fiduciary Trust Co0.00%815,138$21,372,918$21,348,464-$24,454-0.11%
Manufacturers Life Insurance Company, The0.02%811,752$21,284,137$21,259,785-$24,352-0.11%
Two Sigma Investments, Lp0.01%663,877$17,406,855$17,386,939-$19,916-0.11%
Fishman Jay A Ltd/Mi1.24%595,005$15,601,031$15,583,181-$17,850-0.11%
Millennium Management Llc0.01%564,072$14,789,968$14,773,046-$16,922-0.11%
Bnp Paribas Financial Markets0.01%547,278$14,349,629$14,333,211-$16,418-0.11%
Squarepoint Ops Llc0.03%537,747$14,099,726$14,083,594-$16,132-0.11%
Capitolis Liquid Global Markets Llc0.06%500,000$13,110,000$13,095,000-$15,000-0.11%
Nearwater Capital Markets, Ltd0.22%486,700$12,761,274$12,746,673-$14,601-0.11%
Adage Capital Partners Gp, L.L.C.0.02%466,000$12,218,520$12,204,540-$13,980-0.11%
Marshall Wace, Llp0.01%446,866$11,716,827$11,703,421-$13,406-0.11%
Privium Fund Management B.V.1.92%399,367$10,471,403$10,459,422-$11,981-0.11%
Norges Bank0.00%392,300$10,286,106$10,274,337-$11,769-0.11%
Deutsche Bank Ag\0.00%382,682$10,033,923$10,022,442-$11,481-0.11%
Patient Square Capital Lp1.50%370,000$9,701,400$9,690,300-$11,100-0.11%
Point72 Asset Management, L.P.0.01%362,449$9,503,413$9,492,539-$10,874-0.11%

Frequently asked questions about ARQT

  • Who owns the most ARQT stock?

    The largest holders of ARQT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ARCUTIS BIOTHERAPEUTICS INC (ARQT).

  • Is ARQT widely held by superinvestors?

    Many widely followed stocks like ARQT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ARQT is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.